The circadian timing system (CTS) coordinated by the suprachiasmatic nuclei (SCN) of the hypothalamus regulates daily rhythms of behavior, physiology, as well as cellular metabolism and proliferation. Altered circadian rhythms predict for poor survival in cancer patients. An increased incidence of several cancers has been reported in flight attendants and in shift workers. To explore the contribution of the CTS to tumor growth, we developed experimental models of disrupted or enhanced circadian coordination through stereotaxic destruction of the SCN, modifications of photoperiodic or feeding synchronizers and/or the administration of pharmacologic agents. SCN ablation or exposure to experimental chronic jetlag (CJL, consisting of an 8-hour advance of the light-dark cycle every 2 days) caused alterations in circadian physiology and significantly accelerated tumor growth. CJL suppressed or altered the rhythms of clock gene and cell cycle gene expression in mouse liver. It increased p53 and decreased c-Myc expression, a result in line with the promotion of diethylnitrosamine -initiated hepatocarcinogenesis in jet-lagged mice. The accelerating effect of CJL on tumor growth was counterbalanced by the regular timing of food access over the 24-h. Meal timing prevented the circadian disruption produced by CJL and slowed down tumor growth. In synchronized mice, meal timing reinforced host circadian coordination, phase-shifted the transcriptional rhythms of clock genes in the liver of tumor-bearing mice and slowed down cancer progression. These results support the role of the CTS in cancer progression and call for the development of therapeutic strategies aimed at preventing or treating circadian clock dysfunctions.
The circadian timing system (CTS) coordinated by the suprachiasmatic nuclei (SCN) in the hypothalamus regulates daily rhythms of behavior and physiology. 1 Altered circadian rhythms of rest-activity in patients with metastatic colorectal cancer predict for poor survival outcome independently of all known clinical factors. [2] [3] [4] Similarly, an abnormal diurnal salivary cortisol rhythm in patients with metastatic breast cancer predicts for a doubling of the risk of death as compared with those with a near-normal pattern. 5 Epidemiological studies reported an increased incidence of cancers in pilots and in flight attendants performing frequent transmeridian flight. [6] [7] [8] People working night shifts had a significantly greater risk of developing breast, colon, endometrial, and prostate cancer as well as non-Hodgkin lymphoma. [9] [10] [11] [12] [13] [14] [15] [16] [17] The circadian disruption caused by shift work was recognized by the International Agency of Research on Cancer as probably carcinogenic to humans. 18 As a consequence of this decision, the Danish government has begun paying compensation to women who developed breast cancer after working night shifts. So far nearly 40 women diagnosed with breast cancer after working night shifts for more than 20 years have been compensated. 19 To explore the contribution of the CTS to tumor growth, we developed experimental models of disrupted or enhanced coordination of circadian clocks through stereotaxic destruction of the SCN, modifications of photoperiodic or feeding synchronizers, and/or the administration of pharmacological agents.
Disruption of Circadian Coordination
First, the SCN in male B6D2F1 mice were physically destroyed by bilateral electrocoagulation. 20 The destruction of the central clock ablated the 24-hour rest-activity cycle as compared with sham-operated mice. The rhythms in body temperature, serum corticosterone, and circulating lymphocyte count displayed blunted amplitudes and severe phase shifting. These alterations in circadian physiology significantly accelerated the growth rate of 2 transplantable tumors, Glasgow osteosarcoma (GOS) 21 and pancreatic adenocarcinoma (P03). 22 In GOS-bearing mice, on day 12, that is, before the death of the first animal, mean tumor weight (±standard error of the mean [SEM]) reached 1443 ± 203 mg versus 490 ± 96 mg in lesioned and sham mice, respectively (P from t test = .002; Figure 1 ). In mice bearing the more slowly proliferating P03, 22 days after tumor inoculation, the mean tumor weight (±SEM) reached 1447 ± 342 mg in SCN-lesioned animals and 749 ± 136 mg in sham mice (P from t test = .05; Figure 1 ). 23 To mimic the effect of jetlag after frequent eastbound transmeridian flights on tumor development, we subjected the mice to an 8-hour advance of light onset every 2 days for 10 days. Such chronic jetlag (CJL) resulted in severe perturbations in rest-activity, body temperature, and corticosterone rhythms and significantly accelerated the growth rate of GOS as compared with mice remaining on standard light-dark (LD) 12:12 synchronization ( Figure 1 ). 24 On day 11, a t test (P = .001) validated significant differences in tumor weight. In contrast, exposing the mice to constant light or constant darkness exerted no effect on GOS growth rate as compared with mice kept in LD 12:12. The endogenous period in rest-activity and temperature rhythms was shortened to 23.4 hours in constant darkness and lengthened to 26.2 hours in constant light, but the circadian coordination was maintained in both conditions in B6D2F1 mice, a finding divergent from that found in Sprague-Dawley rats. 25 In mice, CJL disrupted circadian rhythms not only in behavior and hormonal levels but also in clock gene expression in the SCN, in the liver, and in the tumor as well. Thus, a highly significant circadian rhythm was found for clock protein mPER1 expression in the SCN of control mice (cosinor; P = .0001). This rhythm was abolished in jet-lagged mice (P = .11). 24 In the liver of control mice, circadian rhythms were statistically validated with cosinor for the mRNA expression of clock genes mRev-erba, mPer2, and Bmal1. CJL severely altered the circadian patterns of all these genes: mean expressions were significantly reduced, whereas amplitudes were damped or suppressed. Cosinor analysis indicated complete rhythm abolition in mRev-era and mBmal1 expression. A significant circadian rhythm persisted in mPer2 expression (P = .012) but with a 42% reduction in double amplitude and a large phase advance, from CT12 to CT4. 26 Several studies have demonstrated that the circadian clock controls the cycling of various genes involved in cell cycle regulation. BMAL1:CLOCK heterodimers negatively control c-Myc expression and as a consequence c-Myc controlled cyclin D and GADD45. BMAL1:CLOCK also trigger Wee1 transcription through an E-box mediated mechanism. 27, 28 Thus, knocking down the circadian clock by CJL should obviously have an effect on cell cycle genes. Indeed, CJL significantly increased the expression level of c-Myc, shifted its peak, and amplified its rhythmicity over 24 hours. In contrast, the mRNA expression of p53 was decreased. Such upregulation of an oncogene and downregulation of a tumor suppressor gene could favor carcinogenesis. That this is effectively the case was demonstrated in mice homozygous for mPer2 mutation (mPer2 m/m ), where the circadian patterns of both genes were altered, and the level of c-Myc was increased. These mutant mice developed more spontaneous and g-radiation induced cancers than the wild type and showed a reduced apoptotic activity in thymocytes. 27 This suggests that the upregulation of c-Myc and downregulation of p53 led to genomic instability, increased proliferation, accumulation of damaged cells, and cancer In our laboratory, we investigated the role of CJL in promoting hepatocarcinogenesis induced by N-nitrosodiethylamine (DEN). Mice bearing temperature-and activity-measuring sensors were synchronized in LD 12:12. They received DEN 10 mg/kg/d intraperitoneally from day 1 to 11, then 7 mg/ kg/d from d21 to d33 and from d41 to d47 (total dose 243 mg/kg). Drug-free intervals were inserted between DEN treatment periods to allow mice to regain weight and recover from DEN toxicity. On d48, after the end of DEN treatment, mice were randomly assigned to either remain in LD synchronization or to undergo experimental CJL. On d297 all the animals were humanely killed, and blood was sampled for transaminase level measurement. Histological studies of tumor presence were performed in the liver, lung, and kidneys. Mean serum aspartate transaminase (ASAT) level, which reflects liver damage, was higher in jet-lagged mice as compared with controls kept in LD 12:12 (386 ± 48 vs 224 ± 26; P = .006).
The frequency of tumors ranged from 1 to 6 per liver in the CJL group and from 1 to 4 in the LD one. The mean diameter of the largest tumor was significantly higher in jet-lagged mice: 8.5 mm vs 4.4 mm (Mann-Whitney test; P = .027).
DEN induced several kinds of hepatic lesions in both groups of mice: hepatocellular carcinomas (HCCs), cholangiocarcinomas, sarcomas, or mixed tumors presenting characteristics of HCC and cholangiocarcinoma. In addition, the mice in the CJL group developed primary lung and kidney tumors. This is in line with the variety of cancers reported in shift workers. Our study and other data further show that mechanisms of carcinogenesis seem to involve circadian disruption caused first by DEN itself then enhanced by CJL. The abolition of plasma corticosterone rhythm and decrease in its mean level associated with DEN carcinogenesis was earlier reported in rats. 29 Daily corticosterone injections around its physiological peak (at zeitgeber [ZT] 8 and 12) could counteract DEN carcinogenesis and delay time of death.
Is circadian disruption a mechanism required for carcinogenesis or facilitating it? This question needs further investigations.
Reinforcement or Induction of Circadian Coordination
We hypothesized that the reinforcement or induction of circadian coordination would slow down tumor growth rate.
To check this hypothesis we used meal timing, which is a strong ZT and was reported to enhance circadian coordination in the liver and in other peripheral organs 30, 31 even in the absence of functional SCN. 32 We inoculated GOS or P03 to mice fed ad libitum and to mice fed only during 4 hours in the light span, from ZT 2 to ZT 6. Meal timing strongly amplified the core body temperature rhythm while shifting its maximum from dark to light span. Similarly, Per2 mRNA expression displayed increased circadian amplitude and 8-hour phase advance. Such enhanced circadian coordination was associated with a significant reduction of the growth rate of GOS 33 and P03 (Li et al, in preparation), as compared with control mice fed ad libitum (Fig 1) .
Meal timing was also able to counterbalance circadian disruption from CJL in mice. Imposing food access for 12 hours on and 12 hours off to mice whose LD schedule was advanced by 8 hours every 2 days entrained the molecular clocks in the liver of GOS-bearing mice as well as in the tumor itself. In the liver, meal timing restored near-normal circadian patterns for mRev-erba and mPer2 expression. In the tumor, mRev-erba, mPer2, and mBmal1 displayed circadian patterns but with acrophases shifted as compared with the healthy liver. This partial restoration of the functional molecular clock in jet-lagged mice resulted in reduced growth rate of GOS (Figure 1 ). 26 The rescue of a defective tumor molecular clock was attempted using seliciclib (aka (R)-Roscovitine, CYC202), 34 a potent inhibitor of cyclin-dependent kinases CDK1, 2, 5, 7, and 9, which arrests the cell cycle at checkpoints G1/S and G2/M. 35 It also interacts with the caseine kinase-1 family (CK1 e and d), 36 an enzyme that regulates the circadian period through the phosphorylation of PER and CRY proteins and their ubiquitination. We hypothesized that seliciclib could reset disrupted tumor clocks in an advanced tumor through transient inhibition of CK1. Seliciclib was administered to GOS-bearing mice at one of two circadian times-ZT3 or ZT19, which correspond to the times of best and worst efficacy, respectively. 37 Seliciclib dosing at ZT3 induced near physiological rhythmic expression of Rev-erba and Per2 with acrophases similar to those found in the healthy liver. After seliciclib at ZT19, the mRNA expression of Rev-erba, Per2, and Bmal1 also became rhythmic, yet with severely damped amplitudes and aberrant acrophases. The administration of seliciclib reduced tumor growth by 55% at ZT3 as compared to 38% at ZT19. Thus, the induction of a functional molecular clock in the tumor was associated with the best antitumor activity of the drug.
Taken together, these experimental results demonstrate that disruption in the CTS accelerates and possibly causes cancer processes in mice. The experimental evidence thus supports the findings in epidemiological and clinical studies, which correlate circadian disruption with increased cancer incidence and accelerated cancer progression. Mechanisms appear to involve the control of the host and tumor cell cycles and apoptosis genes by the host's CTS. Thus, the reinforcement of host and/or tumor clocks through feeding or CDKI slows down tumor progression.
These results call for the development of therapeutic strategies aimed at the prevention and/or the treatment of dysfunctions within the CTS to best prevent and/or control cancer processes.
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